"Preliminary estimates released by the Centers for Disease Control and Prevention indicate that the number of Americans diagnosed with Lyme disease each year is around 300,000. The preliminary estimates were presented Sunday night in Boston at "...
DOSAGE AND ADMINISTRATION
The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. There is insufficient safety information to support doses greater than 30 mg tid. There is also insufficient evidence for additional efficacy of cevimeline hydrochloride at doses greater than 30 mg tid.
EVOXAC (cevimeline hcl) ® is available as white, hard gelatin capsules containing 30 mg of cevimeline hydrochloride. EVOXAC® capsules (cevimeline hcl) have a white opaque cap and a white opaque body. The capsules are imprinted with "EVOXAC (cevimeline hcl) " on the cap and"30 mg" on the body with a black bar above "30 mg". It is supplied in child resistant bottles of:
100 capsules (NDC 63395-201-13)
Store at 25°C (77°F) excursion permitted to 15°-30°C (59°-86°F)
Norman, OK 73072 Distributed and Marketed by: Daiichi Pharmaceutical Corporation Montvale, NJ 07645
EVOXAC (cevimeline hcl) is a registered trademark of Daiichi Pharmaceutical Co., Ltd.
PRT38A Revised 05/2006 Printed in U.S.A. FDA revision date: 12/13/06
Last reviewed on RxList: 2/16/2006
This monograph has been modified to include the generic and brand name in many instances.
Additional Evoxac Information
Evoxac - User Reviews
Evoxac User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options